CBP/p300 and muscle differentiation: no HAT, no muscle
AUTOR(ES)
Polesskaya, A.
FONTE
Oxford University Press
RESUMO
Terminal differentiation of muscle cells follows a precisely orchestrated program of transcriptional regulatory events at the promoters of both muscle-specific and ubiquitous genes. Two distinct families of transcriptional co-activators, GCN5/PCAF and CREB-binding protein (CBP)/p300, are crucial to this process. While both possess histone acetyl-transferase (HAT) activity, previous studies have failed to identify a requirement for CBP/p300 HAT function in myogenic differentiation. We have addressed this issue directly using a chemical inhibitor of CBP/p300 in addition to a negative transdominant mutant. Our results clearly demonstrate that CBP/p300 HAT activity is critical for myogenic terminal differentiation. Furthermore, this requirement is restricted to a subset of events in the differentiation program: cell fusion and specific gene expression. These data help to define the requirements for enzymatic function of distinct coactivators at different stages of the muscle cell differentiation program.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=125755Documentos Relacionados
- A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegans
- Expression of HDAC1 and CBP/p300 in human colorectal carcinomas
- CBP/p300 interact with and function as transcriptional coactivators of BRCA1
- Two contact regions between Stat1 and CBP/p300 in interferon γ signaling
- TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300
